
Mikusu India Acquires Shares in Daikaffil Chemicals, Increasing Stake Through Open Market Purchase
Mikusu India Private Limited has increased its stake in Daikaffil Chemicals India Ltd after acquiring 3,700 equity shares of the target company on June 12, 2026. The acquisition was conducted through the open market of the BSE.The purchase allows Mikusu to boost its holding percentage in Daikaffil. Prior to the transaction, Mikusu held 29,55,388 equity shares, representing 49.26% of the total voting capital. Following the acquisition, the company's stake rose to 29,59,088 shares, which constitutes 49.32% of the issued share capital.
The transaction details indicate that Mikusu India Private Limited holds a controlling interest in Daikaffil Chemicals India Ltd. The company is designated as a Promoter in connection with this acquisition.
Key details regarding the equity structure before and after the purchase are summarized below:
| Metric | Before Acquisition (Mikusu Holding) | After Acquisition (Total Holding) |
|---|---|---|
| Shares Carrying Voting Rights | 29,55,388 (49.26%) | 29,59,088 (49.32%) |
| Total Equity Share Capital | Rs. 6,00,00,000/- (60,00,000 shares of Rs. 10 each) | Rs. 6,00,00,000/- (60,00,000 shares of Rs. 10 each) |
The acquisition consisted solely of shares carrying voting rights and did not involve the purchase of any non-share instruments or encumbered shares. The transaction concluded with the total equity share capital remaining at Rs. 6,00,00,000/- (60,00,000 equity shares of Rs. 10 each).
Stock Price Movement
Daikaffil Chemicals India Ltd settled late Friday at ₹42.97, rallying a strong 4.93%. The shares demonstrated solid intraday movement, trading between a low of ₹40.50 and an intra-day high of ₹42.98.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.